Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 164 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 06/08/20
End: 05/31/27
Due: 05/31/28
Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
Phase: N/A
Priority: Normal
Start: 01/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 07/19/12
End: 09/30/31
Due: 09/30/32
Phase: N/A
Priority: Normal
Start: 05/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 01/27/16
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 01/18/16
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 10/05/21
End: 10/05/26
Due: 10/05/27
Phase: N/A
Priority: Normal
Start: 01/21/20
End: 06/19/23
Due: 06/19/24
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 01/20/22
End: 12/15/24
Due: 12/15/25
Phase: N/A
Priority: Normal
Start: 06/20/23
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 01/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 01/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/29/18
End: 08/22/27
Due: 08/22/28
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 02/03/22
End: 05/15/26
Due: 05/15/27
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 01/31/17
Due: 01/31/18